Founding Kleiner & Perkins [later Kleiner Perkins Caulfield and Byers] and early investments in Tandem Computers and Genentech; chairmanship of Genentech board of directors and executive committee; hiring Robert Swanson at Kleiner & Perkins and initial dealings with Swanson and Herbert Boyer to found Genentech; K & P investment in Cetus; subcontracting early Genentech research to University of California San Francisco, City of Hope, and Caltech; investments in early Genentech's products; licensing and manufacturing strategies; clinical trials and dealings with Food and Drug Administration; invention of clinical research and development partnerships and junior common stock; recruiting Genentech's board; Genentech's IPO; Genentech as model for Hybritech, Inc; Kirk Raab as chief operating officer and relationship with Bob Swanson; licensing agreements with Eli Lily, Kabi Vitrum, and others; FIPCO strategy; Hoffmann-La Rouche acquisition of Genentech; thoughts on investment bankers; patent infringement litigation; comments on Frederick Frank, James Gower, Fred Middleton, David Packard, Kirk Raab, Robert Swanson, Jimmy Treybig and others.